标普生物科技LOF(161127)
动态评分： 6.09分
投资组合
| 报告日期 | 代码 | 名称 | 类型 | 金额(万元) | 占期初比 |
| 2022-12-31 | ALNY | Alnylam Pharmaceuticals Inc | 卖出 | 247.09 | 1.63% |
| 2022-12-31 | CLDX | 塞德斯医疗 | 卖出 | 245.49 | 1.62% |
| 2022-12-31 | SRPT | Sarepta Therapeutics Inc | 卖出 | 243.51 | 1.61% |
| 2022-12-31 | HRTX | Heron Therapeutics Inc | 卖出 | 235.48 | 1.55% |
| 2022-12-31 | DCPH | Deciphera Pharmaceuticals Inc | 卖出 | 225.14 | 1.49% |
| 2022-12-31 | APLS | Apellis Pharmaceuticals Inc | 卖出 | 212.48 | 1.4% |
| 2022-12-31 | VCYT | Veracyte Inc | 卖出 | 204.85 | 1.35% |
| 2022-12-31 | LGND | Ligand Pharmaceuticals Inc | 卖出 | 196.65 | 1.3% |
| 2022-06-30 | TPTX | Turning Point Therapeutics Inc | 卖出 | 448.21 | 2.96% |
| 2022-06-30 | ARNA | Arena Pharmaceuticals Inc | 卖出 | 400.03 | 2.64% |
| 2022-06-30 | TWST | Twist Bioscience Corp | 买入 | 361.71 | 2.39% |
| 2022-06-30 | NVAX | 诺瓦瓦克斯医药 | 买入 | 349.07 | 2.3% |
| 2022-06-30 | NTLA | Intellia Therapeutics Inc | 买入 | 329.62 | 2.18% |
| 2022-06-30 | IOVA | Iovance Biotherapeutics Inc | 买入 | 328.98 | 2.17% |
| 2022-06-30 | FATE | Fate Therapeutics Inc | 买入 | 320.28 | 2.11% |
| 2022-06-30 | SWTX | SpringWorks Therapeutics Inc | 买入 | 320.24 | 2.11% |
| 2022-06-30 | CRSP | CRISPR Therapeutics AG | 买入 | 318.66 | 2.1% |
| 2022-06-30 | EDIT | Editas Medicine Inc | 买入 | 310.54 | 2.05% |
| 2022-06-30 | BCRX | BioCryst Pharmaceuticals Inc | 买入 | 309.75 | 2.04% |
| 2022-06-30 | BEAM | Beam Therapeutics Inc | 买入 | 307.5 | 2.03% |
公告&资料
